Furthermore, a study on the lipophilic extract of seaberry in two breast cancer (BC) cell lines—T47D (ER+, PR+, HER2-) and BT-549 (ER-, PR-, HER2-)—demonstrated concentration-dependent antiproliferative effects. Here, ERBB2 is linked to breast cancer.